New theory of diabetic complications' origin suggests need for new therapeutic approach

Use of anti-oxidants may be ineffective or even contribute to kidney disease and other complications of diabetes, rather than helping to treat such health problems. That conclusion, based on growing unexpected findings that stimulating mitochondrial function and superoxide production results in improved markers of renal, cardiovascular and nerve dysfunction, was presented this week in a "State-of-the-Art Lecture" at the 74th Scientific Sessions of the American Diabetes Association.

"Scientists have long hypothesized that oxidative stress underlies and is driven by mitochondrial production and subsequent free radical damage to proteins and DNA," said Kumar Sharma, M.D., F.A.H.A, U.C. San Diego professor, Director of the Center for Renal Translational Medicine, Division of Nephrology-Hypertension and the Institute of Metabolomic Medicine, and ClinMet scientific founder. "However, clinical trials to date have failed to demonstrate a benefit for anti-oxidant approaches and in some cases, such anti-oxidants have even increased mortality.

"Data from multiple independent investigations, including clinical metabolomics studies, now suggest that in response to excess calories, mitochondrial activity is actually reduced in target tissues for diabetes complications, and such persistent reduction may lead to the release of pro-inflammatory and pro-fibrotic cytokines and subsequent organ dysfunction. Moreover, approaches that restore and mitochondrial superoxide production via exercise, caloric restriction and medications should help promote tissue healing."

Dr. Sharma said that new research measuring real-time superoxide production demonstrated that stimulating such production was linked to improvement in . Additionally he noted that in independent studies in humans, pretreatment of subjects with anti-oxidants (vitamin C and vitamin E) prior to exercise led to a loss in exercise's protective benefits for insulin resistance.

"The new insights relating to the benefits of mitochondrial superoxide production, termed 'mitochondrial hormesis,' has raised many new exciting questions on the mechanisms linking mitochondrial superoxide production to beneficial effects," Dr. Sharma said. "One potential link is that mitochondrial superoxide stimulates the master energy sensor AMPK, which when activated can suppress inflammation and fibrosis. The new theory is also a major boost for drugs that target and support mitochondrial function as potential treatments for diabetic complications and perhaps many other chronic diseases."

add to favorites email to friend print save as pdf

Related Stories

Enzyme restores function with diabetic kidney disease

Oct 25, 2013

Researchers at the University of California, San Diego School of Medicine say that, while a prevailing theory suggests elevated cellular levels of glucose ultimately result in diabetic kidney disease, the ...

A link between type 2 diabetes and mitochondrial function

Oct 01, 2013

Type 2 diabetes is a chronic condition that is characterized by resistance to or insufficient production of insulin, a hormone that controls sugar movement into cells. In certain tissues, insulin resistance has been associated ...

Recommended for you

Growing a blood vessel in a week

19 hours ago

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

22 hours ago

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments